Roche Diagnostics International AG at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Roche Diagnostics International AG at ASHG 2026 in Montréal: 1 presentation (1 poster).

Organization	ASHG 2026 Attendance
Roche Diagnostics International AG Rotkreuz, Switzerland	1 Senior Quality Assurance Specialist
roche.com Subsidiary Roche sells in-vitro diagnostic systems, assays, and sequencing solutions to hospitals, laboratories, clinicians, and researchers. Roche launches Axelios 1 sequencing platform (2026-07) › Roche launches Axelios 1 sequencing platform · 2026-07-23 “Launch of Axelios 1, a transformative next-generation sequencing platform based on the innovative SBX technology” Dan Malarek appointed North America diagnostics CEO · 2026-07-20 “Dan Malarek, current CEO of Foundation Medicine Inc., appointed President and CEO of Roche Diagnostics North America, effective August 1, 2026” Roche agrees to acquire SAGA Diagnostics · 2026-04-23 “Entry into a definitive agreement to acquire SAGA Diagnostics” Source: company newsroom Latest quarter found, Q1 2026: Diagnostics Division sales were CHF 3.3 billion,… › Latest quarter found, Q1 2026: Diagnostics Division sales were CHF 3.3 billion, up 3% at CER and down 7% in reported CHF. 2026 Group-sales outlook: mid-single-digit CER growth. · 2026-04-23 “to CHF 3.3 billion; increase in Group sales in the mid single digit range (CER) for 2026” Source: results release	Poster Wed Oct 21 2:30 pm Part of Omics Technologies Poster Wednesday Session Exome sequencing on the Axelios 1 platform for genetic disease research Exhibit & Poster Hall · Board 8142W Exome/genome sequencingGenomicsLaboratory genetics and genomicsSequencing technology

Organization

ASHG 2026 Attendance

Roche Diagnostics International AG

Rotkreuz, Switzerland

1 Senior Quality Assurance Specialist

roche.com

Subsidiary

Roche sells in-vitro diagnostic systems, assays, and sequencing solutions to hospitals, laboratories, clinicians, and researchers.

Roche launches Axelios 1 sequencing platform (2026-07)

›

Roche launches Axelios 1 sequencing platform · 2026-07-23

“Launch of Axelios 1, a transformative next-generation sequencing platform based on the innovative SBX technology”

Dan Malarek appointed North America diagnostics CEO · 2026-07-20

“Dan Malarek, current CEO of Foundation Medicine Inc., appointed President and CEO of Roche Diagnostics North America, effective August 1, 2026”

Roche agrees to acquire SAGA Diagnostics · 2026-04-23

“Entry into a definitive agreement to acquire SAGA Diagnostics”

Source: company newsroom

Latest quarter found, Q1 2026: Diagnostics Division sales were CHF 3.3 billion,…

›

Latest quarter found, Q1 2026: Diagnostics Division sales were CHF 3.3 billion, up 3% at CER and down 7% in reported CHF. 2026 Group-sales outlook: mid-single-digit CER growth. · 2026-04-23

“to CHF 3.3 billion; increase in Group sales in the mid single digit range (CER) for 2026”

Source: results release

Poster

Wed Oct 21
2:30 pm

Part of Omics Technologies Poster Wednesday Session

Exome sequencing on the Axelios 1 platform for genetic disease research

Exhibit & Poster Hall · Board 8142W

Exome/genome sequencingGenomicsLaboratory genetics and genomicsSequencing technology

Instantly find 20 buyers from Roche Diagnostics International AG

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction